Associate Director, Regulatory Affairs - Biosimilars

Associate Director, Regulatory Affairs - Biosimilars (US)

Sandoz continues to go through an exciting and transformative period as a global leader and pioneering provider of sustainable Biosimilar and Generic medicines. As we continue down this new and ambitious path, unique opportunities will present themselves, both professionally and personally.

Join us, the future is ours to shape!

This position will be located at the Princeton, NJ US Headquarters site. Our Sandoz flexible hybrid working approach allows US office-based employees to work up to 50% of their monthly workday remotely. This role will not have the ability to be located remotely.

Must be authorized to work in the U.S. U.S. work visa sponsorship is not available for this role now or in the future.

Leads and manages the preparation, review, and submission of regulatory applications, including product registrations, progress reports, supplements, amendments, and periodic experience or safety reports. Provides regulatory strategy and guidance to cross‑functional development and project teams, contributing to evidence generation and regulatory positioning to support product approvals.

Serves as a key regulatory liaison throughout the product lifecycle, interacting with regulatory agency personnel to address inquiries, negotiate requirements, and facilitate timely review and approval of submissions. Supports the maintenance of approved status for marketed products and contributes to the successful approval of new drugs, biologics/biotechnology products, and/or medical devices.

Represents Regulatory Affairs on research, development, and marketing project teams, ensuring regulatory considerations are integrated into development and commercialization plans. Advises internal stakeholders on regulatory implications of manufacturing changes, line extensions, labeling updates, and regulatory interpretations. Coordinates and reviews regulatory documents and, as needed, authors submission components to ensure compliance with applicable regulations and alignment with business objectives.

• Develop and lead US regulatory strategies for biosimilar programs from early development through post‑approval lifecycle management.
• Serve as the regulatory subject matter expert on US biosimilar regulations, guidance, and evolving FDA expectations.
• Oversee the preparation, review, and submission of INDs, BLAs (351(k)), amendments, supplements, information request responses, post‑approval commitments, and annual reports.
• Lead and support FDA interactions, including Pre‑IND, Biosimilar Product Development (BPD), and other regulatory and scientific advice meetings.
• Provide regulatory leadership and guidance in partnership with Clinical, Nonclinical, CMC, Analytical Development, Quality, Pharmacovigilance, Medical Affairs, Legal, and Commercial teams.
• Manage post‑approval US regulatory activities, including labeling updates, safety‑related submissions, manufacturing and comparability changes, and inspection readiness support.
• Partner with global development and technical operations teams to ensure high‑quality BLAs, amendments, and supplements that meet FDA requirements.
• Ensure ongoing regulatory compliance with US pre‑ and post‑approval filing, reporting, and regulatory obligations.
• Represent US Regulatory Affairs at internal (US and global) governance forums and external meetings with regulatory authorities and partners.

• Successful implementation of global regulatory strategy for timely submissions and approvals with the best possible labels based on available data.
• Identification of main HA issues
  -Participation in relevant regulatory Boards…